Previous close | 23.46 |
Open | 23.36 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 23.36 - 24.03 |
52-week range | 18.58 - 59.45 |
Volume | |
Avg. volume | 665 |
Market cap | 10.877M |
Beta (5Y monthly) | 1.72 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.79 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SEATTLE, April 25, 2024--As the number one most frequently claimed condition among Trupanion pet parents, allergies in pets are a topic of increasing priority for pet parents. With over 20 years of pet health data, Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, has conducted a deep dive into its veterinary invoice data, revealing trends and insights as well as offering some practical tips for pet parents.
SEATTLE, April 22, 2024--Trupanion (Nasdaq: TRUP), the leading provider of pet medical insurance, is proud to announce the launch of truInsights, an initiative designed to deliver valuable health-related data and insights to pet parents. This initiative will provide a series of discussions covering topics relevant to everyday pet health, offering data-driven insights and practical advice to pet parents.